<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05028387</url>
  </required_header>
  <id_info>
    <org_study_id>1053</org_study_id>
    <nct_id>NCT05028387</nct_id>
  </id_info>
  <brief_title>Telemedicine Medical Abortion Service Using the &quot;No-test&quot; Protocol in Ukraine and Uzbekistan.</brief_title>
  <official_title>Safety and Acceptability of a Telemedicine Medical Abortion Service Using the &quot;No-test&quot; Protocol In Ukraine and Uzbekistan.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charitable Foundation Women Health and Family Planning, Ukraine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Womens Wellness Center, Uzbekistan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to pilot and evaluate a telemedicine medical abortion service&#xD;
      delivery that allows remote communication between the woman and provider and limits medically&#xD;
      unnecessary in-person visits to health or diagnostic centers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence rate of adverse events resulting from remote provision of medical abortion</measure>
    <time_frame>6 weeks</time_frame>
    <description>Adverse events such as regimen non-compliance or medically unnecessary interventions associated with remote provision of medical abortion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with remote provision of medical abortion</measure>
    <time_frame>6 weeks</time_frame>
    <description>Satisfaction with remote provision of medical abortion measures by 5-point Likert scale.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pregnancy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>medical abortion</intervention_name>
    <description>medical abortion</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        People seeking abortion&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Is pregnant as determined by a pregnancy test or ultrasound (if obtained prior to&#xD;
             contacting the study site)&#xD;
&#xD;
          -  Has no contraindications to medical abortion&#xD;
&#xD;
          -  Has access to a phone&#xD;
&#xD;
          -  Is able to take mifepristone on or before 63 days gestation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medically ineligible for medical abortion&#xD;
&#xD;
          -  Gestational age above 63 days based on LMP&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beverly Winikoff, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tamar Tsereteli, MD, PhD</last_name>
    <phone>+995 599 501 229</phone>
    <email>ttsereteli@gynuity.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinic Vrachebnyye Traditsii</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <last_name>Galyna Maystruk, MD</last_name>
      <email>maistruk@rhr.org.ua</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tashkent Medical Academy Clinic</name>
      <address>
        <city>Tashkent</city>
        <country>Uzbekistan</country>
      </address>
    </facility>
    <contact>
      <last_name>Dilfuza Kurbanbekova, MD</last_name>
    </contact>
    <contact_backup>
      <email>drdilfuzabegim@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Ukraine</country>
    <country>Uzbekistan</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>August 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2021</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

